Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Breast cancer medical oncologist
Harold Burstein, MD, PhD, from the
Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute, explains what an aromatase inhibitor is, and how and when it is used in
treating breast cancer.
Breast cancer medical oncologist Harold Burstein, MD, PhD, explains the difference between tamoxifen and aromatase inhibitors, and the use of each for the treatment of breast cancer.
Learn more about Dana-Farber/Brigham and Women's Cancer Center's
Breast Oncology Program, and how we diagnose and treat
Appointments and Second Opinions
For adults: 877-442-3324For children: 888-733-4662